Removal of subdural-peritoneal shunts in infants

Case Series on Removal of Subdural to Peritoneal Shunt After Resolution of Subdural Collection in the First 2 Years of Life

BACKGROUND

Subdural to peritoneal shunt (SPS) placement is an established treatment option for chronic subdural hematoma (SDH) in the pediatric population. Practice patterns vary between institutions, with some advocating shunt removal while others leave the SPS in place after SDH resolution. There remain a paucity of data to document the safety and outcomes after removal of SPS.

OBJECTIVE

To support the safety and efficacy of SPS placement and subsequent removal for chronic SDH in children younger than 2 years.

METHODS

A total of 26 patients younger than 2 years underwent SPS removal procedures over a 5-year period from 2015 to 2019 at a single institution. Patient characteristics, hospital course, and outcomes were prospectively recorded in the hospital electronic medical record. Attention was given to change in head circumference, size of subdural collection, need for reoperation, or complications because of shunt removal.

RESULTS

Patients who underwent SPS placement presented with macrocephaly, signs and symptoms of increased intracranial pressure, and radiographical evidence of subdural collections. The most common etiology of chronic SDH was nonaccidental head trauma (18 of 26 patients). SDS was kept in place for an average of 10 months. Resolution of SDH was demonstrated on imaging for all 26 patients. One patient did require reinsertion of SPS 2 weeks after SPS removal.

CONCLUSION

Removal of SPS remains controversial, and careful consideration of patient, family, and provider preferences and potential risks associated with SPS removal must be taken into consideration.

Clinical outcomes of temporary shunting for infants with cerebral pseudomeningocele

OBJECTIVE

Although in the case of subdural collections temporary shunting has been suggested as a viable alternative for definitive drainage of the accumulated fluid until restoration of the normal CSF dynamics, there is no agreement on the best management strategy for pseudomeningocele.

METHODS

The authors performed a retrospective chart review in order to evaluate the clinical outcomes of infants temporarily shunted for pseudomeningocele without encephalocele at our institution (The University of Illinois at Peoria/Illinois Neurological Institute) in the period from 2004 to 2012. The epidemiological characteristics, clinical management, and final outcomes of such subpopulation were compared with a control group which received temporary shunting for subdural hematomas (SDH) during the same period.

RESULTS

Four patients (100% male) ranging in age from 8.9 to 27.1 months (mean = 13.88) with pseudomeningocele and 17 patients (64.7% male) ranging in age from 1.9 to 11.8 months (mean = 4.15) with SDH were identified. Although the initial management included sequential percutaneous subdural tapping in 82% of the patients, all children ultimately failed such strategy, requiring either subdural-peritoneal (81% of the cases) or subgaleal-peritoneal (19% of the cases) shunting. The mean implant duration was 201 days for the pseudomeningocele group and 384 days for the SDH one. Mean post-shunt hospitalization was 2 days for patients with pseudomeningocele and 4 days for patients with SDH. There was no statistical difference in terms of complications, length of hospitalization post-shunting, or clinical outcomes between the patients with pseudomeningocele and those with SDH.

CONCLUSIONS

Temporary shunting of infants with pseudo-meningocele constitutes a viable therapeutic alternative with favorable clinical outcomes and a low risk of shunt dependency similar to those of children with SDH.

Signs and symptoms of cerebrospinal fluid shunt malfunction in the pediatric emergency department

OBJECTIVES

Pediatric patients with cerebrospinal fluid shunts frequently present to the emergency department for evaluation of possible shunt malfunction. Most shunt studies appear in the neurosurgical literature. To our knowledge, none have reviewed presenting signs and symptoms of shunt malfunction in patients who present to the pediatric emergency department. The study objective was to evaluate the medical record of children with cerebrospinal fluid shunts who presented to a pediatric emergency department to determine if any signs and/or symptoms were predictive of shunt malfunction.

METHODS

A retrospective chart review was conducted on 352 pediatric patients aged 0 to 18 years, who presented to the pediatric emergency department between January 1, 1998, and December 31, 2002, with signs and/or symptoms that prompted an evaluation for possible shunt malfunction.

RESULTS

Univariate analysis of all signs and symptoms revealed lethargy (odds ratio, 1.99; 95% confidence interval, 1.15-3.42; P = 0.02) and shunt site swelling (odds ratio, 2.56, 95% confidence interval, 1.08-6.07, P = 0.03) to be significantly predictive of shunt malfunction. Logistic regression analysis continued to show significance for lethargy (odds ratio, 2.20; bias-corrected 95% confidence interval, 1.11-3.63) and shunt site swelling (odds ratio, 3.10; bias-corrected 95% confidence interval, 1.38-9.05), but found no other study variable to be significant. Bootstrap resampling validated the importance of the significant variables identified in the regression analysis.

CONCLUSIONS

In this study, lethargy and shunt site swelling were predictive of shunt malfunction. Other signs and symptoms studied did not reach statistical significance; however, one must maintain a high index of suspicion when evaluating children with an intracranial shunt because the presentation of malfunction is widely varied. A missed diagnosis can result in permanent neurological sequelae or even death.